William L. Mitchell

Molybdenum(II)-Catalyzed Allylation of Electron-Rich Aromatics and Heteroaromatics

Andrei V. Malkov, Stuart L. Davis, Ian R. Baxendale et al. · The Journal of Organic Chemistry · 1999 · 132 citations · Full text

Inorganic Chemistry, Chemical Engineering, Cross-coupling Reaction +10

Discovery of 2-[(2,4-Dichlorophenyl)amino]- <i>N</i> -[(tetrahydro- 2 <i>H</i> -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain

Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor et al. · Journal of Medicinal Chemistry · 2007 · 120 citations · Full text

Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease

Leticia Toledo‐Sherman, Michael E. Prime, Ladislav Mrzljak et al. · Journal of Medicinal Chemistry · 2015 · 61 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Neurodegenerative Diseases +15

2,8′-Disubstituted-1,1′-Binaphthyls: A New Pattern in Chiral Ligands

Štěpán Vyskočil, L. Meca, I. Tišlerová et al. · Chemistry - A European Journal · 2002 · 60 citations

Asymmetric Catalysis, Engineering, New Pattern +9

Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB₂Agonist for the Treatment of Chronic Pain

Gerard M.P. Giblin, Andrew Billinton, Michael A. Briggs et al. · Journal of Medicinal Chemistry · 2009 · 53 citations · Full text